Show simple item record

Authordc.contributor.authorGonzalo Godoy, J. 
Authordc.contributor.authorGutiérrez, Vicente 
Authordc.contributor.authorMontecinos, Mario 
Authordc.contributor.authorYenes, Alejandro 
Admission datedc.date.accessioned2019-03-15T16:09:04Z
Available datedc.date.available2019-03-15T16:09:04Z
Publication datedc.date.issued2015
Cita de ítemdc.identifier.citationRevista Medica de Chile, Volumen 143, Issue 1, 2018, Pages 63-68
Identifierdc.identifier.issn07176163
Identifierdc.identifier.issn00349887
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/166408
Abstractdc.description.abstract© 2015, Sociedad Medica de Santiago. All rights reserved. Background: Vildagliptin is a dipeptidyl peptidase IV inhibitor (DPP4i). Its efficacy and safety of DPP4i in Chilean real life type 2 diabetic (T2D) patients is not well known. Aim: To assess the safety profile and effectiveness of 12 weeks of treatment with Vildagliptin for glycemic control in T2D Chilean patients with a poor glycemic control. Patients and Methods: Retrospective assessment of the effects of Vildagliptin treatment during 12 weeks in 103 T2D patients aged 29 to 92 years (47% males). The main outcomes were changes in glycosylated hemoglobin and the occurrence of adverse effects. Results: After 12 weeks of Vildagliptin use, glycosylated hemoglobin decreased from 8.3 ± 1.4 to 7.2 ± 1.1% (p < 0.01). Fasting plasma glucose and the number of hypoglycemic events also decreased significantly. No significant weight change was observed. The treatment had good compliance, tolerance and patient satisfaction. Conclusions: Vil
Lenguagedc.language.isoen
Publisherdc.publisherSociedad Medica de Santiago
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista Medica de Chile
Keywordsdc.subjectAdamantane
Keywordsdc.subjectHypoglycemic agents
Keywordsdc.subjectPragmatic clinical trials as topics
Títulodc.titleSafety and efficacy of vildagliptin in real life chilean diabetic patients Evaluación del perfil de eficacia y seguridad de vildagliptina en vida real de pacientes chilenos con diabetes mellitus tipo 2
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile